Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30+
SponsorAffiliated Hospital of Nantong University

About this trial

The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with hypertension;

Diagnosed with diabetes;

Diagnosed with atrial fibrillation;

Smoking subjects;

Disqualifiers

Diagnosed with malignancies;

Diagnosed with psychiatric disorders;

Diagnosed with cognitive impairment;

Unable to operate smart wearable devices.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Wearable Devices

    Behavioral

    Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: With Wearable DevicesExperimental treatment 1 intervention
Group B: Without Wearable DevicesNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

medication adherence and risk factor control rates

1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.

Time frame
6 months

Secondary outcomes

1

incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events

Stroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.